Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
9 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 8(2); May 2015
Prev issue Next issue
Review Articles
Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes
Ruth H. Walker
J Mov Disord. 2015;8(2):41-54.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15009
  • 28,421 View
  • 349 Download
  • 38 Web of Science
  • 32 Crossref
AbstractAbstract PDF
There have been significant advances in neuroacanthocytosis (NA) syndromes in the past 20 years, however, confusion still exists regarding the precise nature of these disorders and the correct nomenclature. This article seeks to clarify these issues and to summarise the recent literature in the field. The four key NA syndromes are described here–chorea-acanthocytosis, McLeod syndrome, Huntington’s disease-like 2, and pantothenate kinase- associated neurodegeneration. In the first two, acanthocytosis is a frequent, although not invariable, finding; in the second two, it occurs in approximately 10% of patients. Degeneration affecting the basal ganglia is the key neuropathologic finding, thus the clinical presentations can be remarkably similar. The characteristic phenotype comprises a variety of movement disorders, including chorea, dystonia, and parkinsonism, and also psychiatric and cognitive symptoms attributable to basal ganglia dysfunction. The age of onset, inheritance patterns, and ethnic background differ in each condition, providing diagnostic clues. Other investigations, including routine blood testing and neuroimaging can be informative. Genetic diagnosis, if available, provides a definitive diagnosis, and is important for genetic counseling, and hopefully molecular therapies in the future. In this article I provide a historical perspective on each NA syndrome. The first 3 disorders, chorea-acanthocytosis, McLeod syndrome, Huntington’s disease-like 2, are discussed in detail, with a comprehensive review of the literature to date for each, while pantothenate kinase-associated neurodegeneration is presented in summary, as this disorder has recently been reviewed in this journal. Therapy for all of these diseases is, at present, purely symptomatic.

Citations

Citations to this article as recorded by  
  • Identification of four novel mutations in VSP13A in Iranian patients with Chorea-acanthocytosis (ChAc)
    Vadieh Ghodsinezhad, Abdoreza Ghoreishi, Mohammad Rohani, Mahdi Dadfar, Akbar Mohammadzadeh, Ali Rostami, Hamzeh Rahimi
    Molecular Genetics and Genomics.2024;[Epub]     CrossRef
  • Acupuncture for treating symptoms associated with chorea-acanthocytosis: A CARE-compliant case report
    Qiqi Wu, Zengtu Li, Yingying Cheng, Hantong Hu, Hong Gao, Jiawei Wang, Dexiong Han
    EXPLORE.2023; 19(1): 127.     CrossRef
  • Two case reports of chorea-acanthocytosis and review of literature
    Shuangfeng Huang, Junliang Zhang, Manli Tao, Yaodong Lv, Luyao Xu, Zhigang Liang
    European Journal of Medical Research.2022;[Epub]     CrossRef
  • Skin Conditions and Movement Disorders: Hiding in Plain Sight
    Kristina Kulcsarova, Janette Baloghova, Jan Necpal, Matej Skorvanek
    Movement Disorders Clinical Practice.2022; 9(5): 566.     CrossRef
  • The XK plasma membrane scramblase and the VPS13A cytosolic lipid transporter for ATP‐induced cell death
    Yuta Ryoden, Shigekazu Nagata
    BioEssays.2022;[Epub]     CrossRef
  • Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data
    Weibin He, Chenhui Li, Hongjuan Dong, Lingmin Shao, Bo Yin, Dianyou Li, Liguo Ye, Ping Hu, Chencheng Zhang, Wei Yi
    Journal of Movement Disorders.2022; 15(3): 197.     CrossRef
  • Chorea-acanthocytosis: Time-dependent changes of symptoms and imaging findings
    Fumio Suzuki, Noriko Sato, Atsuhiko Sugiyama, Keiya Iijima, Yoko Shigemoto, Emiko Morimoto, Yukio Kimura, Hiroyuki Fujii, Yuji Takahashi, Yasuhiro Nakata, Hiroshi Matsuda, Osamu Abe
    Journal of Neuroradiology.2021; 48(6): 419.     CrossRef
  • Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases
    K.N. Anderson, W.B. Overcast, J.R. Brosch, B.D. Graner, M.C. Veronesi
    Neurographics.2021; 11(2): 127.     CrossRef
  • Brain F-18 FDG and F-18 FP-CIT PET/CT Findings of c.856_860delCTCTA Mutation McLeod Syndrome
    Ho-Sung Ryu, Chae Moon Hong
    Cognitive and Behavioral Neurology.2021; 34(3): 207.     CrossRef
  • Vacuolar Protein-Sorting Receptor MoVps13 Regulates Conidiation and Pathogenicity in Rice Blast Fungus Magnaporthe oryzae
    Xueming Zhu, Lin Li, Jiaoyu Wang, Lili Zhao, Huanbin Shi, Jiandong Bao, Zhenzhu Su, Xiaohong Liu, Fucheng Lin
    Journal of Fungi.2021; 7(12): 1084.     CrossRef
  • Involuntary movements, vocalizations and cognitive decline
    Olafur Sveinsson, Bjarne Udd, Per Svenningsson, Christoph Gassner, Charlotte Engström, José Laffita-Mesa, Göran Solders, Stellan Hertegård, Irina Savitcheva, Hans H. Jung, Markus Tolnay, Beat M. Frey, Martin Paucar
    Parkinsonism & Related Disorders.2020; 79: 135.     CrossRef
  • Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis
    Fumio Suzuki, Noriko Sato, Miho Ota, Atsuhiko Sugiyama, Yoko Shigemoto, Emiko Morimoto, Yukio Kimura, Noritaka Wakasugi, Yuji Takahashi, Akinori Futamura, Mitsuru Kawamura, Kenjiro Ono, Masayuki Nakamura, Akira Sano, Masako Watanabe, Hiroshi Matsuda, Osam
    Journal of the Neurological Sciences.2020; 408: 116545.     CrossRef
  • Identification of two compound heterozygous VPS13A large deletions in chorea‐acanthocytosis only by protein and quantitative DNA analysis
    Derek Spieler, Antonio Velayos‐Baeza, Alžbeta Mühlbäck, Florian Castrop, Christian Maegerlein, Julia Slotta‐Huspenina, Benedikt Bader, Bernhard Haslinger, Adrian Danek
    Molecular Genetics & Genomic Medicine.2020;[Epub]     CrossRef
  • Neuroacanthocytosis with unusual clinical features
    Hui Zhu, Xue-min Feng, Teng Zhao, Jing-yao Liu
    Medicine.2019; 98(2): e14050.     CrossRef
  • VPS13A, a closely associated mitochondrial protein, is required for efficient lysosomal degradation
    Sandra Muñoz-Braceras, Alba R. Tornero-Écija, Olivier Vincent, Ricardo Escalante
    Disease Models & Mechanisms.2019;[Epub]     CrossRef
  • Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
    Nicki Niemann, Joseph Jankovic
    Parkinsonism & Related Disorders.2019; 67: 74.     CrossRef
  • Chorea
    Pichet Termsarasab
    CONTINUUM: Lifelong Learning in Neurology.2019; 25(4): 1001.     CrossRef
  • Chorea-acanthocytosis
    Susan Walker, Rubina Dad, Bhooma Thiruvahindrapuram, Muhammed Ikram Ullah, Arsalan Ahmad, Muhammad Jawad Hassan, Stephen W. Scherer, Berge A. Minassian
    Neurology Genetics.2018;[Epub]     CrossRef
  • Huntington's disease-like disorders in Latin America and the Caribbean
    Ruth H. Walker, Emilia M. Gatto, M. Leonor Bustamante, Oscar Bernal-Pacheco, Francisco Cardoso, Raphael M. Castilhos, Pedro Chana-Cuevas, Mario Cornejo-Olivas, Ingrid Estrada-Bellmann, Laura B. Jardim, Ricardo López-Castellanos, Ricardo López-Contreras, D
    Parkinsonism & Related Disorders.2018; 53: 10.     CrossRef
  • Feeding Dystonia
    Ritu Shree, Sahil Mehta, Venugopalan Y. Vishnu
    Movement Disorders Clinical Practice.2018; 5(4): 442.     CrossRef
  • Comment on: Consequences of Delayed Dental Extraction in Lesch‐Nyhan Disease
    Harriet Van Den Tooren, Benjamin M. Davies, Monty Silverdale, David McKee
    Movement Disorders Clinical Practice.2017; 4(3): 463.     CrossRef
  • Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review
    Yan Shen, Xiaoming Liu, Xi Long, Chao Han, Fang Wan, Wenliang Fan, Xingfang Guo, Kai Ma, Shiyi Guo, Luxi Wang, Yun Xia, Ling Liu, Jinsha Huang, Zhicheng Lin, Nian Xiong, Tao Wang
    Frontiers in Aging Neuroscience.2017;[Epub]     CrossRef
  • Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome
    Christoph Gassner, Chantal Brönnimann, Yvonne Merki, Maja P. Mattle‐Greminger, Sonja Sigurdardottir, Eduardo Meyer, Charlotte Engström, John D. O'Sullivan, Hans H. Jung, Beat M. Frey
    Transfusion.2017; 57(9): 2125.     CrossRef
  • Disruption of GABA(A)-mediated intracortical inhibition in patients with chorea-acanthocytosis
    Raffaele Dubbioso, Marcello Esposito, Silvio Peluso, Rosa Iodice, Giuseppe De Michele, Lucio Santoro, Fiore Manganelli
    Neuroscience Letters.2017; 654: 107.     CrossRef
  • The First Genetically Confirmed McLeod Syndrome in Korea
    Kye Won Park, Soo Jeong, Eul-Ju Seo, Chong S. Lee
    Journal of the Korean Neurological Association.2017; 35(2): 85.     CrossRef
  • Hippocampal sclerosis and mesial temporal lobe epilepsy in chorea‐acanthocytosis: a case with clinical, pathologic and genetic evaluation
    K. Mente, S. A. Kim, C. Grunseich, M. M. Hefti, J. F. Crary, A. Danek, B. I. Karp, R. H. Walker
    Neuropathology and Applied Neurobiology.2017; 43(6): 542.     CrossRef
  • Yeast and other lower eukaryotic organisms for studies of Vps13 proteins in health and disease
    Weronika Rzepnikowska, Krzysztof Flis, Sandra Muñoz‐Braceras, Regina Menezes, Ricardo Escalante, Teresa Zoladek
    Traffic.2017; 18(11): 711.     CrossRef
  • Peripheral neuropathy in complex inherited diseases: an approach to diagnosis
    Alexander M Rossor, Aisling S Carr, Helen Devine, Hoskote Chandrashekar, Ana Lara Pelayo-Negro, Davide Pareyson, Michael E Shy, Steven S Scherer, Mary M Reilly
    Journal of Neurology, Neurosurgery & Psychiatry.2017; 88(10): 846.     CrossRef
  • Huntington's Disease, Huntington's Disease Look‐Alikes‎, and Benign Hereditary Chorea: What's New?
    Susanne A. Schneider, Thomas Bird
    Movement Disorders Clinical Practice.2016; 3(4): 342.     CrossRef
  • Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
    Jae-Hyeok Lee, Jongkyu Park, Ho-Sung Ryu, Hyeyoung Park, Young Eun Kim, Jin Yong Hong, Sang Ook Nam, Young-Hee Sung, Seung-Hwan Lee, Jee-Young Lee, Myung Jun Lee, Tae-Hyoung Kim, Chul Hyoung Lyoo, Sun Ju Chung, Seong Beom Koh, Phil Hyu Lee, Jin Whan Cho,
    Journal of Movement Disorders.2016; 9(1): 20.     CrossRef
  • Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach
    Davide Tonduti, Luisa Chiapparini, Isabella Moroni, Anna Ardissone, Giovanna Zorzi, Federica Zibordi, Sergio Raspante, Celeste Panteghini, Barbara Garavaglia, Nardo Nardocci
    Current Neurology and Neuroscience Reports.2016;[Epub]     CrossRef
  • Clinical variability of neuroacanthocytosis syndromes—a series of six patients with long follow-up
    J. Dulski, W. Sołtan, M. Schinwelski, M. Rudzińska, M. Wójcik-Pędziwiatr, L. Wictor, F. Schön, A. Puschmann, J. Klempíř, L. Tilley, J. Roth, P. Tacik, S. Fujioka, W. Drozdowski, E.J. Sitek, Z. Wszolek, J. Sławek
    Clinical Neurology and Neurosurgery.2016; 147: 78.     CrossRef
123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
Eun Joo Chung, Sang Jin Kim
J Mov Disord. 2015;8(2):55-66.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15015
  • 18,268 View
  • 193 Download
  • 45 Web of Science
  • 43 Crossref
AbstractAbstract PDF
Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, which have abnormal aggregations of α-synuclein in the nigral and extranigral areas, including in the heart. 123I-metaiodobenzylguanidine (MIBG) scintigraphy is a well-known tool to evaluate cardiac sympathetic denervation in the Lewy body-related disorders. MIBG scintigraphy showed low uptake of MIBG in the Lewy body-related disorders, including Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure and rapid eye movement sleep behavior disorder. This review summarizes previous results on the diagnostic applications of MIBG scintigraphy in Lewy body-related disorders.

Citations

Citations to this article as recorded by  
  • Sudden cardiac death in synucleinopathies
    Keivan Javanshiri, Tove Drakenberg, Mattias Haglund, Elisabet Englund
    Journal of Neuropathology & Experimental Neurology.2023; 82(3): 242.     CrossRef
  • Optimal Protocol and Clinical Usefulness of 123I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson’s Disease and Dementia with Lewy Body from Non-Parkinson’s Diseases
    In Kook Chun
    Nuclear Medicine and Molecular Imaging.2023; 57(3): 145.     CrossRef
  • Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
    Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
    Brain Sciences.2023; 13(10): 1471.     CrossRef
  • Differentiating Dementia with Lewy Bodies from Alzheimer's Disease Using the Fall Risk Evaluation Questionnaire
    Masashi Tsujimoto, Keisuke Suzuki, Akinori Takeda, Naoki Saji, Takashi Sakurai, Yukihiko Washimi
    Internal Medicine.2022; 61(11): 1687.     CrossRef
  • Association of plasma α-synuclein with cardiac 123I-MIBG scintigraphy in early Parkinson’s disease
    Don Gueu Park, Juhee Kang, Young-Sil An, Jaerak Chang, Jung Han Yoon
    Neuroscience Letters.2022; 770: 136399.     CrossRef
  • Clinical and imaging evidence of brain-first and body-first Parkinson's disease
    Jacob Horsager, Karoline Knudsen, Michael Sommerauer
    Neurobiology of Disease.2022; 164: 105626.     CrossRef
  • Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
    Keivan Javanshiri, Tove Drakenberg, Mattias Haglund, Elisabet Englund
    Journal of Parkinson's Disease.2022; 12(4): 1125.     CrossRef
  • Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age
    G. Roberts, J.J. Lloyd, J.P.M. Kane, R. Durcan, S. Lawley, K. Howe, G.S. Petrides, J.T. O’Brien, A.J. Thomas
    Journal of Nuclear Cardiology.2021; 28(4): 1692.     CrossRef
  • Uniformity of cardiac 123I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia
    Gemma Roberts, Jim J. Lloyd, Elizabeth Jefferson, Joseph P.M. Kane, Rory Durcan, Sarah Lawley, George S. Petrides, Kim Howe, Iftikhar Haq, John T. O’Brien, Alan J. Thomas
    Journal of Nuclear Cardiology.2021; 28(5): 2151.     CrossRef
  • Myocardial Sympathetic Innervation Imaging with MIBG in Dementia with Lewy Bodies
    Gagandeep Choudhary, Pradeep Bhambhvani
    Journal of Nuclear Cardiology.2021; 28(5): 2164.     CrossRef
  • Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
    Juhee Kang, Jae Whan Kim, Hansol Heo, Jihyun Lee, Kwan Yong Park, Jung Han Yoon, Jaerak Chang
    Clinical and Translational Science.2021; 14(2): 606.     CrossRef
  • Gastrointestinal Dysfunction in Parkinson’s Disease
    Casper Skjærbæk, Karoline Knudsen, Jacob Horsager, Per Borghammer
    Journal of Clinical Medicine.2021; 10(3): 493.     CrossRef
  • Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson’s Disease—a Systematic Review
    Vasiliki Katsi, Ilias Papakonstantinou, Eirini Solomou, Alexios S. Antonopoulos, Charalambos Vlachopoulos, Konstantinos Tsioufis
    Current Hypertension Reports.2021;[Epub]     CrossRef
  • Lewy Body Dementias: A Coin with Two Sides?
    Ángela Milán-Tomás, Marta Fernández-Matarrubia, María Cruz Rodríguez-Oroz
    Behavioral Sciences.2021; 11(7): 94.     CrossRef
  • Cardiac Autonomic Dysfunction Is Associated with Severity of REM Sleep without Atonia in Isolated REM Sleep Behavior Disorder
    Sooyeoun You, Kyoung Sook Won, Keun Tae Kim, Hyang Woon Lee, Yong Won Cho
    Journal of Clinical Medicine.2021; 10(22): 5414.     CrossRef
  • A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index
    Fumi Sakamoto, Shinya Shiraishi, Koji Ogasawara, Noriko Tsuda, Masataka Nakagawa, Seiji Tomiguchi, Yasuyuki Yamashita
    Annals of Nuclear Medicine.2020; 34(6): 415.     CrossRef
  • Difference in cardiovascular response during orthostatic stress in Parkinson’s disease and multiple system atrophy
    Tomohiko Nakamura, Masashi Suzuki, Masamichi Ueda, Yumiko Harada, Masaaki Hirayama, Masahisa Katsuno
    Journal of Neural Transmission.2020; 127(10): 1377.     CrossRef
  • Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease
    Yoon-Sang Oh, Joong-Seok Kim, Sang-Won Yoo, Eo-Jin Hwang, Chul Hyoung Lyoo, Kwang-Soo Lee
    Parkinsonism & Related Disorders.2019; 63: 156.     CrossRef
  • Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes
    Dong-Woo Ryu, Joong-Seok Kim, Jee-Eun Lee, Yoon-Sang Oh, Sang-Won Yoo, Ie Ryung Yoo, Kwang-Soo Lee
    Clinical Nuclear Medicine.2019; 44(4): 282.     CrossRef
  • Cardiac 123I-MIBG planar heart to mediastinum ratios depend on patient size; phantom studies suggest SPECT-CT could improve quantification
    Gemma Roberts, Jim J Lloyd, George S Petrides, John T O’Brien, Alan J Thomas
    Biomedical Physics & Engineering Express.2019; 6(1): 015011.     CrossRef
  • Does sympathetic dysfunction occur before denervation in pure autonomic failure?
    Ling Guo, Murray D. Esler, Carolina Sari, Sarah Phillips, Elisabeth A. Lambert, Nora E. Straznicky, Gavin W. Lambert, Susan J. Corcoran
    Clinical Science.2018; 132(1): 1.     CrossRef
  • Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study
    Dan Xu, Wenjia Zhu, Li Huo, Shikun Zhu, Fang Li, Han Wang
    Parkinsonism & Related Disorders.2018;[Epub]     CrossRef
  • Extensive Delayed Brain Atrophy after Resuscitation in a Patient with Multiple System Atrophy
    Sazuku Nisitani, Hirofumi Miyoshi, Yoji Katsuoka
    Frontiers in Neurology.2018;[Epub]     CrossRef
  • Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
    J. William Langston, Jesse C. Wiley, Michele Tagliati
    npj Parkinson's Disease.2018;[Epub]     CrossRef
  • Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
    Ilaria Cova, Alberto Priori
    Journal of Neural Transmission.2018; 125(10): 1417.     CrossRef
  • Imaging the Autonomic Nervous System in Parkinson’s Disease
    Karoline Knudsen, Per Borghammer
    Current Neurology and Neuroscience Reports.2018;[Epub]     CrossRef
  • A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment
    Samuel D. Capouch, Martin R. Farlow, Jared R. Brosch
    Neurology and Therapy.2018; 7(2): 249.     CrossRef
  • The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes
    Eiji Matsusue, Yoshio Fujihara, Kenichiro Tanaka, Yuki Aozasa, Manabu Shimoda, Hiroyuki Nakayasu, Kazuhiko Nakamura, Toshihide Ogawa
    Yonago Acta Medica.2018; 61(2): 117.     CrossRef
  • Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging
    Yusuke Inoue, Yutaka Abe, Kei Kikuchi, Keiji Matsunaga, Ray Masuda, Kazutoshi Nishiyama
    Journal of Nuclear Cardiology.2017; 24(5): 1725.     CrossRef
  • Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
    J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee
    European Journal of Neurology.2017; 24(2): 349.     CrossRef
  • Diagnosis of dementia with Lewy bodies: can123I-IMP and123I-MIBG scintigraphy yield new core features?
    Fumi Sakamoto, Shinya Shiraishi, Noriko Tsuda, Mamoru Hashimoto, Seiji Tomiguchi, Manabu Ikeda, Yasuyuki Yamashita
    The British Journal of Radiology.2017; 90(1070): 20160156.     CrossRef
  • Imaging Parkinson’s disease below the neck
    Per Borghammer, Karoline Knudsen, Tatyana D. Fedorova, David J. Brooks
    npj Parkinson's Disease.2017;[Epub]     CrossRef
  • The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
    Naoto Uyama, Hideki Otsuka, Takayoshi Shinya, Yoichi Otomi, Masafumi Harada, Wataru Sako, Yuishin Izumi, Ryuji Kaji, Yuya Watanabe, Satoru Takashi, Yamato Kunikane
    Nuclear Medicine Communications.2017; 38(6): 487.     CrossRef
  • Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study
    Mun Hee Choi, Jung Han Yoon, Suk Woo Yong
    Journal of the Neurological Sciences.2017; 381: 291.     CrossRef
  • Cardiovascular autonomic dysfunctions in elderly patients with essential tremor: comparison with healthy controls
    Joong-Seok Kim, Yoon-Sang Oh, Hyung-Eun Park, Si-Hoon Lee, Jeong-Wook Park, In-Uk Song, Jae-Young An, Hun-Jun Park, Byung-Chul Son, Kwang-Soo Lee
    Neurological Sciences.2016; 37(5): 711.     CrossRef
  • Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
    Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, Si-Hoon Lee, Jeong-Wook Park, Byung-chul Son, Kwang-Soo Lee
    Journal of the Neurological Sciences.2016; 362: 59.     CrossRef
  • [123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
    J. J. van der Zande, J. Booij, P. Scheltens, P. G. H. M. Raijmakers, A. W. Lemstra
    European Journal of Nuclear Medicine and Molecular Imaging.2016; 43(6): 1060.     CrossRef
  • Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies?
    Flavio Nobili, Dario Arnaldi, Silvia Morbelli
    European Journal of Nuclear Medicine and Molecular Imaging.2016; 43(6): 1056.     CrossRef
  • Imaging Systemic Dysfunction in Parkinson’s Disease
    Per Borghammer, Karoline Knudsen, David J. Brooks
    Current Neurology and Neuroscience Reports.2016;[Epub]     CrossRef
  • 123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study
    Pietro Tiraboschi, Angelo Corso, Ugo Paolo Guerra, Flavio Nobili, Arnoldo Piccardo, Maria Lucia Calcagni, Duccio Volterrani, Diego Cecchin, Mauro Tettamanti, Luigi Antelmi, Simone Vidale, Leonardo Sacco, Maria Merello, Stefano Stefanini, Anna Micheli, Pao
    Annals of Neurology.2016; 80(3): 368.     CrossRef
  • On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases
    Hayato Odagiri, Toru Baba, Yoshiyuki Nishio, Osamu Iizuka, Minoru Matsuda, Kentaro Inoue, Akio Kikuchi, Takafumi Hasegawa, Masashi Aoki, Atsushi Takeda, Yasuyuki Taki, Etsuro Mori, John Duda
    PLOS ONE.2016; 11(4): e0152746.     CrossRef
  • 123I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease
    Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, In-Uk Song, Dong-Won Yang, Jeong-Wook Park, Kwang-Soo Lee
    Journal of the Neurological Sciences.2015; 357(1-2): 173.     CrossRef
  • Orthostatic hypotension: managing a difficult problem
    Pearl K Jones, Brett H Shaw, Satish R Raj
    Expert Review of Cardiovascular Therapy.2015; 13(11): 1263.     CrossRef
Hereditary Cerebellar Ataxias: A Korean Perspective
Ji Sun Kim, Jin Whan Cho
J Mov Disord. 2015;8(2):67-75.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15006
  • 15,975 View
  • 228 Download
  • 14 Web of Science
  • 13 Crossref
AbstractAbstract PDF
Hereditary ataxia is a heterogeneous disorder characterized by progressive ataxia combined with/without peripheral neuropathy, extrapyramidal symptoms, pyramidal symptoms, seizure, and multiple systematic involvements. More than 35 autosomal dominant cerebellar ataxias have been designated as spinocerebellar ataxia, and there are 55 recessive ataxias that have not been named systematically. Conducting genetic sequencing to confirm a diagnosis is difficult due to the large amount of subtypes with phenotypic overlap. The prevalence of hereditary ataxia can vary among countries, and estimations of prevalence and subtype frequencies are necessary for planning a diagnostic strategy in a specific population. This review covers the various hereditary ataxias reported in the Korean population with a focus on the prevalence and subtype frequencies as the clinical characteristics of the various subtypes.

Citations

Citations to this article as recorded by  
  • Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials
    Ji-Hyun Choi, Chaewon Shin, Han-Joon Kim, Beomseok Jeon
    Journal of Neurology.2022; 269(1): 62.     CrossRef
  • New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors
    Fabiola V. Borbolla-Jiménez, María Luisa Del Prado-Audelo, Bulmaro Cisneros, Isaac H. Caballero-Florán, Gerardo Leyva-Gómez, Jonathan J. Magaña
    Pharmaceutics.2021; 13(7): 1018.     CrossRef
  • Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
    Hye-Rim Shin, Jangsup Moon, Woo-Jin Lee, Han Sang Lee, Eun Young Kim, Seoyi Shin, Soon-Tae Lee, Keun-Hwa Jung, Kyung-Il Park, Ki-Young Jung, Sang Kun Lee, Kon Chu
    Scientific Reports.2021;[Epub]     CrossRef
  • Essential tremor: the most common form of cerebellar degeneration?
    Elan D. Louis, Phyllis L. Faust
    Cerebellum & Ataxias.2020;[Epub]     CrossRef
  • Identifying SYNE1 ataxia and extending the mutational spectrum in Korea
    Ji Sun Kim, Ah Reum Kim, Jinyoung Youn, Chung Lee, Nam-Soon Kim, Woong-Yang Park, Jong Kyu Park, Nayoung K.D. Kim, Jin Whan Cho
    Parkinsonism & Related Disorders.2019; 58: 74.     CrossRef
  • Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations
    Hiroya Naruse, Takashi Matsukawa, Hiroyuki Ishiura, Jun Mitsui, Yuji Takahashi, Hiroki Takano, Jun Goto, Tatsushi Toda, Shoji Tsuji
    neurogenetics.2019; 20(2): 65.     CrossRef
  • Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
    Szu‐Ju Chen, Ni‐Chung Lee, Yin‐Hsiu Chien, Wuh‐Liang Hwu, Chin‐Hsien Lin
    Brain and Behavior.2019;[Epub]     CrossRef
  • Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias
    Minkyeong Kim, Jong Hyeon Ahn, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Jin Whan Cho
    Scientific Reports.2019;[Epub]     CrossRef
  • The Etiologies of Chronic Progressive Cerebellar Ataxia in a Korean Population
    Ji Sun Kim, Soonwook Kwon, Chang-Seok Ki, Jinyoung Youn, Jin Whan Cho
    Journal of Clinical Neurology.2018; 14(3): 374.     CrossRef
  • Cross-cultural adaptation and validation of the International Cooperative Ataxia Rating Scale (ICARS) to Brazilian Portuguese
    Fernanda Aparecida Maggi, Pedro Braga-Neto, Hsin Fen Chien, Maria Thereza Drumond Gama, Flávio Moura Rezende Filho, Maria Luiza Saraiva-Pereira, Laura Bannach Jardim, Mariana Callil Voos, José Luiz Pedroso, Orlando Graziani Povoas Barsottini
    Arquivos de Neuro-Psiquiatria.2018; 76(10): 674.     CrossRef
  • The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
    Woo-Jin Lee, Jangsup Moon, Tae-Joon Kim, Jin-Sun Jun, Han Sang Lee, Young Jin Ryu, Soon-Tae Lee, Keun-Hwa Jung, Kyung-Il Park, Ki-Young Jung, Manho Kim, Sang Kun Lee, Kon Chu
    Journal of Neuroimmunology.2017; 309: 82.     CrossRef
  • Genetic Variants Associated with Episodic Ataxia in Korea
    Kwang-Dong Choi, Ji-Soo Kim, Hyo-Jung Kim, Ileok Jung, Seong-Hae Jeong, Seung-Han Lee, Dong Uk Kim, Sang-Ho Kim, Seo Young Choi, Jin-Hong Shin, Dae-Seong Kim, Kyung-Pil Park, Hyang-Sook Kim, Jae-Hwan Choi
    Scientific Reports.2017;[Epub]     CrossRef
  • Ataxia with Oculomotor Apraxia Type 1 without Oculomotor Apraxia: A Case Report
    Minwoo Lee, Nan Young Kim, Jin Young Huh, Young Eun Kim, Yun Joong Kim
    Journal of Clinical Neurology.2016; 12(1): 126.     CrossRef
Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease
Joong-Seok Kim, Hye-Young Sung
J Mov Disord. 2015;8(2):76-82.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15008
  • 41,302 View
  • 265 Download
  • 41 Web of Science
  • 44 Crossref
AbstractAbstract PDF
Currently, gastrointestinal dysfunctions in Parkinson’s disease (PD) are well-recognized problems and are known to be an initial symptom in the pathological process that eventually results in PD. Gastrointestinal symptoms may result from the involvement of either the central or enteric nervous systems, or these symptoms may be side effects of antiparkinsonian medications. Weight loss, excessive salivation, dysphagia, nausea/gastroparesis, constipation, and defecation dysfunction all may occur. Increased identification and early detection of these symptoms can result in a significant improvement in the quality of life for PD patients.

Citations

Citations to this article as recorded by  
  • Regulation of Pain Perception by Microbiota in Parkinson Disease
    Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco, Habibeh Khoshbouei
    Pharmacological Reviews.2024; 76(1): 7.     CrossRef
  • Emerging wearable technologies for multisystem monitoring and treatment of Parkinson’s disease: a narrative review
    Yasmine M. Kehnemouyi, Todd P. Coleman, Peter A. Tass
    Frontiers in Network Physiology.2024;[Epub]     CrossRef
  • N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis
    Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang
    Brain Research Bulletin.2023; 202: 110729.     CrossRef
  • Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
    Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi
    Anesthesiology and Pain Medicine.2023;[Epub]     CrossRef
  • Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
    Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi
    CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008.     CrossRef
  • A look back at the prodromal findings in Parkinson’s disease
    Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
    Bulletin of the National Research Centre.2023;[Epub]     CrossRef
  • Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
    Xuxiang Zhang, Beisha Tang, Jifeng Guo
    Translational Neurodegeneration.2023;[Epub]     CrossRef
  • Association between malnutrition and motor/non-motor symptoms in elderly with Parkinson disease
    Heewon Bae, Sang-Won Ha
    Journal of Geriatric Neurology.2023; 2(2): 58.     CrossRef
  • Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life
    Nir Bar, Amel Karaa, Katheryn Kiser, Braden Kuo, Claire Zar-Kessler
    Clinical and Translational Gastroenterology.2023; 14(12): e00633.     CrossRef
  • Nutritional aspects in Parkinson’s disease
    Paulina Gątarek, Joanna Kałużna-Czaplińska
    Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467.     CrossRef
  • Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
    Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
    Nutrients.2022; 14(2): 380.     CrossRef
  • Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
    Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen
    European Journal of Inflammation.2022; 20: 1721727X2210837.     CrossRef
  • Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
    Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal
    Folia Microbiologica.2022; 67(5): 693.     CrossRef
  • Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
    Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi
    Journal of Molecular Neuroscience.2022; 72(9): 1952.     CrossRef
  • Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
    Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
    Yasir Bashir, Asad U. Khan
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
    Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun
    Microbial Pathogenesis.2021; 150: 104675.     CrossRef
  • Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
    Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
    Acta Pharmaceutica Sinica B.2021;[Epub]     CrossRef
  • Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
    Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl
    International Journal of Molecular Sciences.2021; 22(6): 3233.     CrossRef
  • Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
    Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye
    Neurochemical Research.2021; 46(11): 3050.     CrossRef
  • ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
    Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness
    Journal of Parkinson's Disease.2021; 11(4): 1821.     CrossRef
  • The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
    Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
    Pharmacological Research.2021; 172: 105840.     CrossRef
  • Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
    Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee
    Brain, Behavior, and Immunity.2021; 98: 357.     CrossRef
  • Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
    Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau
    Neurotoxicity Research.2021; 39(6): 2141.     CrossRef
  • Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang
    Microbiome.2021;[Epub]     CrossRef
  • Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease
    Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness
    Neurogastroenterology & Motility.2020;[Epub]     CrossRef
  • Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
    Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa
    European Journal of Pharmaceutical Sciences.2020; 147: 105280.     CrossRef
  • Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa
    Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano
    Revista Brasileira de Geriatria e Gerontologia.2020;[Epub]     CrossRef
  • Probiotics for Parkinson’s Disease
    Gazerani
    International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
  • Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
    Eliseu da Cruz Moreira-Junior
    Medical Hypotheses.2019; 133: 109399.     CrossRef
  • Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
    Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao
    Current Neurovascular Research.2019; 16(3): 241.     CrossRef
  • α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon
    M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong
    Neuroscience.2019; 423: 76.     CrossRef
  • Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
    Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen
    Brain, Behavior, and Immunity.2018; 70: 48.     CrossRef
  • Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
    Meng-Fei Sun, Yan-Qin Shen
    Ageing Research Reviews.2018; 45: 53.     CrossRef
  • Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
    Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
    British Journal of Clinical Pharmacology.2018; 84(11): 2551.     CrossRef
  • Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial
    Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab
    Clinical Neuropharmacology.2018; 41(5): 151.     CrossRef
  • Role of Microbiota in Neurodegenerative Diseases
    C. V. Sobol
    Russian Journal of Developmental Biology.2018; 49(6): 297.     CrossRef
  • α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
    Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
    Neurological Sciences.2017; 38(1): 171.     CrossRef
  • Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
    Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
    Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
  • Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
    Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim
    Expert Review of Neurotherapeutics.2017; 17(7): 737.     CrossRef
  • Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
    Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu
    Brain Research.2016; 1642: 180.     CrossRef
  • Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
    Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi
    Parkinsonism & Related Disorders.2016;[Epub]     CrossRef
  • An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient
    Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park
    Korean Journal of Spine.2015; 12(3): 153.     CrossRef
Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Han-Joon Kim, Beom S. Jeon, Sun Ha Paek
J Mov Disord. 2015;8(2):83-91.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15010
  • 24,429 View
  • 246 Download
  • 54 Web of Science
  • 46 Crossref
AbstractAbstract PDF
Subthalamic deep brain stimulation (STN DBS) is an established treatment for the motor symptoms in patients with advanced Parkinson’s disease (PD). In addition to improvements in motor symptoms, many studies have reported changes in various nonmotor symptoms (NMSs) after STN DBS in patients with PD. Psychiatric symptoms, including depression, apathy, anxiety, and impulsivity, can worsen or improve depending on the electrical stimulation parameters, the locations of the stimulating contacts within the STN, and changes in medications after surgery. Global cognitive function is not affected by STN DBS, and there is no increase in the incidence of dementia after STN DBS compared to that after medical treatment, although clinically insignificant declines in verbal fluency have been consistently reported. Pain, especially PD-related pain, improves with STN DBS. Evidence regarding the effects of STN DBS on autonomic symptoms and sleep-related problems is limited and remains conflicting. Many symptoms of nonmotor fluctuations, which are occasionally more troublesome than motor fluctuations, improve with STN DBS. Although it is clear that NMSs are not target symptoms for STN DBS, NMSs have a strong influence on the quality of life of patients with PD, and clinicians should thus be aware of these NMSs when deciding whether to perform surgery and should pay attention to changes in these symptoms after STN DBS to ensure the optimal care for patients.

Citations

Citations to this article as recorded by  
  • Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study
    Ying Gao, Jue Wang, Linbin Wang, Dianyou Li, Bomin Sun, Xian Qiu, Shiek Ahmed
    Parkinson's Disease.2024; 2024: 1.     CrossRef
  • Neurocognitive changes at different follow-up times after bilateral subthalamic nucleus deep brain stimulation in patients with Parkinson's disease
    Zhuohang Wang, Zijian Zheng, Junwen Huang, Xu Cai, Xinjie Liu, Cheng Xue, Longping Yao, Guohui Lu
    Heliyon.2024; 10(4): e26303.     CrossRef
  • A Wellness Prescription for Parkinson's: Mid to Late-stage Disease
    Gregory M Pontone, Bradley McDaniels, Adrienne M Keener, Indu Subramanian
    The American Journal of Geriatric Psychiatry.2023;[Epub]     CrossRef
  • Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses
    G. Brand, C. Bontempi, L. Jacquot
    Revue Neurologique.2023; 179(9): 947.     CrossRef
  • Time-locked acute alpha-frequency stimulation of subthalamic nuclei during the evaluation of emotional stimuli and its effect on power modulation
    Naeem Muhammad, Saurabh Sonkusare, Qiong Ding, Linbin Wang, Alekhya Mandali, Yi Jie Zhao, Bomin Sun, Dianyou Li, Valerie Voon
    Frontiers in Human Neuroscience.2023;[Epub]     CrossRef
  • Nutraceuticals a Food for Thought in the Treatment of Parkinson’s Disease
    Keshav Bansal, Sakshi Singh, Vanshita Singh, Meenakshi Bajpai
    Current Nutrition & Food Science.2023; 19(9): 961.     CrossRef
  • Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial
    Silje Bjerknes, Mathias Toft, Reidun Brandt, Trine Waage Rygvold, Ane Konglund, Espen Dietrichs, Stein Andersson, Inger Marie Skogseid
    Movement Disorders Clinical Practice.2022; 9(1): 48.     CrossRef
  • Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis
    Zahra Eghlidos, Zahra Rahimian, Gholamreza Vadiee, Soodeh Jahangiri
    Acta Neurologica Scandinavica.2022; 146(2): 115.     CrossRef
  • Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson’s Disease
    Bowen Chang, Chen Ni, Jiaming Mei, Chi Xiong, Peng Chen, Manli Jiang, Chaoshi Niu
    Brain Sciences.2022; 12(7): 841.     CrossRef
  • A nigra–subthalamic circuit is involved in acute and chronic pain states
    Cui Yin, Tao Jia, Yiwen Luan, Xue Zhang, Cheng Xiao, Chunyi Zhou
    Pain.2022; 163(10): 1952.     CrossRef
  • A nigro–subthalamo–parabrachial pathway modulates pain-like behaviors
    Tao Jia, Ying-Di Wang, Jing Chen, Xue Zhang, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
    Nature Communications.2022;[Epub]     CrossRef
  • Basal impulses: findings from the last twenty years on impulsivity and reward pathways using deep brain stimulation
    Pavan S. UPADHYAYULA, Robert C. RENNERT, Joel R. MARTIN, John K. YUE, Jason YANG, Eva M. GILLIS-BUCK, Nikki SIDHU, Christopher K. CHEUNG, Anthony T. LEE, Reid R. HOSHIDE, Joseph D. CIACCI
    Journal of Neurosurgical Sciences.2021;[Epub]     CrossRef
  • Pallidal versus subthalamic deep-brain stimulation for meige syndrome: a retrospective study
    Jiayu Liu, Hu Ding, Ke Xu, Ruen Liu, Dongliang Wang, Jia Ouyang, Zhi Liu, Zeyu Miao
    Scientific Reports.2021;[Epub]     CrossRef
  • Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity
    Lulu Jiang, Wanru Chen, Qiyu Guo, Chao Yang, Jing Gu, Wenbiao Xian, Yanmei Liu, Yifan Zheng, Jing Ye, Shaohua Xu, Yu Hu, Lei Wu, Jie Chen, Hao Qian, Xiaoli Fu, Jinlong Liu, Ling Chen
    CNS Neuroscience & Therapeutics.2021; 27(11): 1366.     CrossRef
  • Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease
    Gabriele Bellini, Laura A. Best, Una Brechany, Russell Mills, Nicola Pavese
    Movement Disorders Clinical Practice.2020; 7(4): 373.     CrossRef
  • Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice
    Yiwen Luan, Dongliang Tang, Haichuan Wu, Weixin Gu, Yuqing Wu, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
    Proceedings of the National Academy of Sciences.2020; 117(18): 10045.     CrossRef
  • Impulsivity and Compulsivity After Subthalamic Deep Brain Stimulation for Parkinson’s Disease
    Sara Scherrer, Andrew H. Smith, Jaimie Gowatsky, Christina A. Palmese, Joohi Jimenez-Shahed, Brian H. Kopell, Helen S. Mayberg, Martijn Figee
    Frontiers in Behavioral Neuroscience.2020;[Epub]     CrossRef
  • Deep brain stimulation and recordings: Insights into the contributions of subthalamic nucleus in cognition
    Neil M. Drummond, Robert Chen
    NeuroImage.2020; 222: 117300.     CrossRef
  • Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center Experience
    Hye Ran Park, Yong Hoon Lim, Eun Jin Song, Jae Meen Lee, Kawngwoo Park, Kwang Hyon Park, Woong-Woo Lee, Han-Joon Kim, Beomseok Jeon, Sun Ha Paek
    Journal of Clinical Medicine.2020; 9(9): 3044.     CrossRef
  • Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease
    Silje Bjerknes, Inger Marie Skogseid, Tuva Jin Hauge, Espen Dietrichs, Mathias Toft
    npj Parkinson's Disease.2020;[Epub]     CrossRef
  • Impacto de la estimulación subtalámica a largo plazo sobre la situación cognitiva de los pacientes con enfermedad de Parkinson avanzada
    M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
    Neurología.2019; 34(9): 573.     CrossRef
  • The Subthalamic Nucleus: Unravelling New Roles and Mechanisms in the Control of Action
    Tora Bonnevie, Kareem A. Zaghloul
    The Neuroscientist.2019; 25(1): 48.     CrossRef
  • Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease
    U. Hidding, A. Gulberti, C. Pflug, C. Choe, A. Horn, L. Prilop, H. Braaß, O. Fründt, C. Buhmann, D. Weiss, M. Westphal, A.K. Engel, C. Gerloff, J.A. Köppen, W. Hamel, C.K.E. Moll, M. Pötter-Nerger
    Parkinsonism & Related Disorders.2019; 62: 141.     CrossRef
  • Zona incerta GABAergic neurons integrate prey-related sensory signals and induce an appetitive drive to promote hunting
    Zheng-dong Zhao, Zongming Chen, Xinkuan Xiang, Mengna Hu, Hengchang Xie, Xiaoning Jia, Fang Cai, Yuting Cui, Zijun Chen, Lechen Qian, Jiashu Liu, Congping Shang, Yiqing Yang, Xinyan Ni, Wenzhi Sun, Ji Hu, Peng Cao, Haohong Li, Wei L. Shen
    Nature Neuroscience.2019; 22(6): 921.     CrossRef
  • Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson's disease
    M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
    Neurología (English Edition).2019; 34(9): 573.     CrossRef
  • Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson
    J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
    Neurología.2018; 33(3): 154.     CrossRef
  • Alteration in the Local and Global Functional Connectivity of Resting State Networks in Parkinson’s Disease
    Maryam Ghahremani, Jaejun Yoo, Sun Ju Chung, Kwangsun Yoo, Jong C. Ye, Yong Jeong
    Journal of Movement Disorders.2018; 11(1): 13.     CrossRef
  • Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden
    J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
    Neurología (English Edition).2018; 33(3): 154.     CrossRef
  • Clinical Markers of Anxiety Subtypes in Parkinson Disease
    Martinus P. G. Broen, A. F. G. Leentjens, J. T. Hinkle, A. J. H. Moonen, M. L. Kuijf, N. M. Fischer, K. Perepezko, A. Bakker, G. M. Pontone
    Journal of Geriatric Psychiatry and Neurology.2018; 31(2): 55.     CrossRef
  • Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: A Meta-Analysis
    Ying Wang, Yongsheng Li, Xiaona Zhang, Anmu Xie
    Parkinson's Disease.2018; 2018: 1.     CrossRef
  • Non-motor Characterization of the Basal Ganglia: Evidence From Human and Non-human Primate Electrophysiology
    Robert S. Eisinger, Morgan E. Urdaneta, Kelly D. Foote, Michael S. Okun, Aysegul Gunduz
    Frontiers in Neuroscience.2018;[Epub]     CrossRef
  • Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing
    Arnaud Pautrat, Marta Rolland, Margaux Barthelemy, Christelle Baunez, Valérie Sinniger, Brigitte Piallat, Marc Savasta, Paul G Overton, Olivier David, Veronique Coizet
    eLife.2018;[Epub]     CrossRef
  • Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery—A retrospective analysis of patients that underwent surgery between 1993 and 2001
    Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist
    Clinical Neurology and Neurosurgery.2018; 174: 174.     CrossRef
  • Predictors to quality of life improvements after subthalamic stimulation in Parkinson’s disease
    Feng‐Tao Liu, Li‐Qin Lang, Yu‐Jie Yang, Jue Zhao, Rui Feng, Jie Hu, Jian Wang, Jian‐Jun Wu
    Acta Neurologica Scandinavica.2018;[Epub]     CrossRef
  • Apathy associated with neurocognitive disorders: Recent progress and future directions
    Krista L. Lanctôt, Luis Agüera‐Ortiz, Henry Brodaty, Paul T. Francis, Yonas E. Geda, Zahinoor Ismail, Gad A. Marshall, Moyra E. Mortby, Chiadi U. Onyike, Prasad R. Padala, Antonios M. Politis, Paul B. Rosenberg, Emma Siegel, David L. Sultzer, Eleenor H. A
    Alzheimer's & Dementia.2017; 13(1): 84.     CrossRef
  • Can deep brain stimulation be a therapeutic option for Parkinson's disease dementia?
    Han‐Joon Kim, Beomseok Jeon, Jee‐Young Lee, Sun Ha Paek
    Neurology and Clinical Neuroscience.2017; 5(1): 3.     CrossRef
  • The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence
    Mónica M Kurtis, Thadshani Rajah, Luisa F Delgado, Haidar S Dafsari
    npj Parkinson's Disease.2017;[Epub]     CrossRef
  • Delayed responses of subthalamic nucleus to deep brain stimulation in patients with Parkinson's disease
    Lin Shi, Kai Zhang, Fan-Gang Meng, Guan-Yu Zhu, Ying-Chuan Chen, Jun-Jian Zhou, Zhong-Hai Zhou, Jian-Guo Zhang
    Parkinsonism & Related Disorders.2017; 40: 76.     CrossRef
  • Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease
    Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, Mario M. Rosa, Daisy Abreu, Nilza Gonçalves, Angelo Antonini, Joaquim J. Ferreira
    Parkinsonism & Related Disorders.2017;[Epub]     CrossRef
  • Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals
    Kathrin Badstuebner, Ulrike Gimsa, Immo Weber, Armin Tuchscherer, Jan Gimsa
    Parkinson's Disease.2017; 2017: 1.     CrossRef
  • Current Topics in Deep Brain Stimulation for Parkinson Disease
    Atsushi UMEMURA, Genko OYAMA, Yasushi SHIMO, Madoka NAKAJIMA, Asuka NAKAJIMA, Takayuki JO, Satoko SEKIMOTO, Masanobu ITO, Takumi MITSUHASHI, Nobutaka HATTORI, Hajime ARAI
    Neurologia medico-chirurgica.2016; 56(10): 613.     CrossRef
  • In Parkinson’s disease STN stimulation enhances responsiveness of movement initiation speed to high reward value
    Maja Kojovic, Andrea Higgins, Marjan Jahanshahi
    Neuropsychologia.2016; 89: 273.     CrossRef
  • Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson’s Disease
    Lei-Fang Cao, Xiao-Yan Peng, Ya Huang, Bing Wang, Feng-Ming Zhou, Ruo-Xiao Cheng, Li-Hua Chen, Wei-Feng Luo, Tong Liu
    Neural Plasticity.2016; 2016: 1.     CrossRef
  • The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
    Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
    Journal of Clinical Neurology.2016; 12(4): 393.     CrossRef
  • Antiparkinsonian Treatment for Depression in Parkinson's Disease: Are Selective Serotonin Reuptake Inhibitors Recommended?
    Philippe De Deurwaerdère, Yuqiang Ding
    Translational Neuroscience and Clinics.2016; 2(2): 138.     CrossRef
  • The Subthalamic Nucleus, Limbic Function, and Impulse Control
    P. Justin Rossi, Aysegul Gunduz, Michael S. Okun
    Neuropsychology Review.2015; 25(4): 398.     CrossRef
Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease
Hye Mi Lee, Seong-Beom Koh
J Mov Disord. 2015;8(2):92-97.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15003
  • 22,049 View
  • 540 Download
  • 95 Web of Science
  • 93 Crossref
AbstractAbstract PDF
Parkinson’s disease (PD) is a multi-systemic disorder that is characterized by a combination of motor and non-motor symptoms (NMS). The dopaminergic neurodegeneration of PD is involved in the genesis of NMS, but other conditions and side effects of levodopa are also associated with NMS. NMS can develop at all stage of PD and rapid eyeball movement sleep behavior disorder (RBD), constipation, depression, and olfactory dysfunction are considered prodromal signs of PD. Many NMS related with motor deficits and cognitive dysfunction. Some NMS including olfactory dysfunction, RBD and abnormal stereopsis are associated with presence of other NMS of PD. In addition, several NMS can be helpful to differentiate between idiopathic PD and other parkinsonian disorders. Early recognition and management of NMS in PD patients is important for preserving quality of life.

Citations

Citations to this article as recorded by  
  • Challenges in Managing Nonmotor Symptoms of Parkinson's Disease in Low‐Resourced Settings with Unavailability of Newer Drugs
    Zakiyah Aldaajani, Hanan Khalil
    Movement Disorders Clinical Practice.2024; 11(2): 123.     CrossRef
  • Is there any correlation between alpha-synuclein levels in tears and retinal layer thickness in Parkinson's disease?
    Azyadeh Camacho-Ordonez, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Ana Jimena Hernandez-Medrano, Selma Alin Somilleda-Ventura, Hector J. Pérez-Cano, Ángel Nava-Castañeda, Oscar Guerrero-Berger
    European Journal of Ophthalmology.2024; 34(1): 252.     CrossRef
  • Robotic technology for Parkinson's disease: Needs, attitudes and concerns of individuals with Parkinson's disease and their family members. A focus group study
    Azriel Kaplan, Shirel Barkan-Slater, Yair Zlotnik, Shelly Levy-Tzedek
    International Journal of Human-Computer Studies.2024; 181: 103148.     CrossRef
  • Associations of dual-task walking costs with cognition in Parkinson’s disease
    Danial Kazemi, Amir Shayan Chadeganipour, Mina Dehghani, Fatemeh Ghorbali
    Gait & Posture.2024;[Epub]     CrossRef
  • Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease
    Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Esrafil Mansouri, Somayeh Hajipour, Samireh Ghafouri, Nima Bakhtiari, Alireza Sarkaki, Yaghoob Farbood
    Behavioural Brain Research.2023; 437: 114100.     CrossRef
  • The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial
    Sanaz Mehrabani, Fariborz Khorvash, Zahra Heidari, Maryam Tajabadi-Ebrahimi, Reza Amani
    Journal of Functional Foods.2023; 100: 105397.     CrossRef
  • Role of Ceramides and Sphingolipids in Parkinson's Disease
    Melissa Vos, Christine Klein, Andrew A Hicks
    Journal of Molecular Biology.2023; 435(12): 168000.     CrossRef
  • Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson’s disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials
    Purumea Jun, HuiYan Zhao, In Chul Jung, Ojin Kwon, Chang-Hyun Han, Jiyoon Won, Jung-Hee Jang
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms
    Syed Omar Ahmad, Jason Longhurst, Dana Stiles, Lana Downard, Stephanie Martin
    Neuroscience Letters.2023; 801: 137162.     CrossRef
  • Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
    Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki, Elisabeth Vardaka
    Medicina.2023; 59(3): 504.     CrossRef
  • Case management interventions in chronic disease reduce anxiety and depressive symptoms: A systematic review and meta-analysis
    Angelika D. Geerlings, Jules M. Janssen Daalen, Jan H. L. Ypinga, Bastiaan R. Bloem, Marjan J. Meinders, Marten Munneke, Sirwan K. L. Darweesh, Vincenzo De Luca
    PLOS ONE.2023; 18(4): e0282590.     CrossRef
  • Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models
    Sanaz Salaramoli, Hamed Amiri, Hamid Reza Joshaghani, Mahmoud Hosseini, Seyed Isaac Hashemy
    Metabolic Brain Disease.2023; 38(6): 2055.     CrossRef
  • Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
    Poornima D.E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong-Sun Kim, Changjong Moon
    Current Neuropharmacology.2023; 21(3): 560.     CrossRef
  • Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
    Dutta Rajib
    Journal of Neuroscience and Neurological Disorders.2023; 7(2): 027.     CrossRef
  • The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
    Viviana A. Ruiz-Pozo, Rafael Tamayo-Trujillo, Santiago Cadena-Ullauri, Evelyn Frias-Toral, Patricia Guevara-Ramírez, Elius Paz-Cruz, Sebastián Chapela, Martha Montalván, Tania Morales-López, Daniel Simancas-Racines, Ana Karina Zambrano
    Nutrients.2023; 15(16): 3585.     CrossRef
  • Enhancing Parkinson's disease severity assessment through voice-based wavelet scattering, optimized model selection, and weighted majority voting
    Farhad Abedinzadeh Torghabeh, Seyyed Abed Hosseini, Elham Ahmadi Moghadam
    Medicine in Novel Technology and Devices.2023; 20: 100266.     CrossRef
  • A look back at the prodromal findings in Parkinson’s disease
    Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
    Bulletin of the National Research Centre.2023;[Epub]     CrossRef
  • Parkinson’s Disease Non-Motor Subtypes Classification in a Group of Slovenian Patients: Actuarial vs. Data-Driven Approach
    Timotej Petrijan, Jan Zmazek, Marija Menih
    Journal of Clinical Medicine.2023; 12(23): 7434.     CrossRef
  • Unveiling the Hidden Challenges: Non-Motor Disorders in Parkinson’s Disease
    Francisco Nieto-Escamez, Esteban Obrero-Gaitán, Héctor García-López, Irene Cortés-Pérez
    Brain Sciences.2023; 13(12): 1710.     CrossRef
  • REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease
    Kangfu Yin, Chuanbin Zhou, Yongyun Zhu, Weifang Yin, Lei Yin, Bin Liu, Hui Ren, Zhong Xu, Xinglong Yang
    Aging Clinical and Experimental Research.2022; 34(1): 159.     CrossRef
  • Gender Differences and Impact of Autonomic Disturbance on Fatigue and Quality of Life in Parkinson's Disease
    NahushR Bansal, BirinderS Paul, Gunchan Paul, Gagandeep Singh
    Neurology India.2022; 70(1): 203.     CrossRef
  • Exploring Unmet Information Needs of People with Parkinson’s Disease and Their Families: Focusing on Information Sharing in an Online Patient Community
    Hyeon Sik Chu, Hye Young Jang
    International Journal of Environmental Research and Public Health.2022; 19(5): 2521.     CrossRef
  • Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen
    European Journal of Inflammation.2022; 20: 1721727X2210837.     CrossRef
  • Diffusion Tensor Imaging Reveals Deep Brain Structure Changes in Early Parkinson’s Disease Patients with Various Sleep Disorders
    Yanyan Jiang, Hedi An, Qian Xi, Weiting Yang, Hongrong Xie, Yang Li, Dongya Huang
    Brain Sciences.2022; 12(4): 463.     CrossRef
  • Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
    Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
    Journal of Clinical Neurology.2022; 18(3): 259.     CrossRef
  • Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson's disease: Randomized controlled trial
    Yusun Park, Sung Reul Kim, Hui Young So, Sungyang Jo, Seung Hyun Lee, Yun su Hwang, Mi Sun Kim, Sun Ju Chung
    Geriatric Nursing.2022; 46: 90.     CrossRef
  • Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
    Milind V. Masule, Sumit Rathod, Yogeeta Agrawal, Chandragouda R. Patil, Kartik T. Nakhate, Shreesh Ojha, Sameer N. Goyal, Umesh B. Mahajan
    Current Research in Pharmacology and Drug Discovery.2022; 3: 100113.     CrossRef
  • Psychosis in Parkinson’s Disease: A Lesson from Genetics
    Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, Chiara Villa
    Genes.2022; 13(6): 1099.     CrossRef
  • Non-motor manifestation of Parkinson's disease: a cross-sectional study in a teaching hospital in Jordan
    Said Salah Dahbour, Mohammad J. Al Murr, Liyan H. Oweis, Nada T. Al Antary, Maram Mohsen, Safa Al Fegi
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2022;[Epub]     CrossRef
  • Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study
    Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri
    Journal of Immunoassay and Immunochemistry.2021; 42(2): 106.     CrossRef
  • SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
    Ana Gómez-López, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
    Brain Sciences.2021; 11(1): 57.     CrossRef
  • People with Parkinson’s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?
    Rebecca J. Port, Martin Rumsby, Graham Brown, Ian F. Harrison, Anneesa Amjad, Claire J. Bale
    Journal of Parkinson's Disease.2021; 11(2): 715.     CrossRef
  • Rho‐kinase inhibition by fasudil modulates pre‐synaptic vesicle dynamics
    Kim Ann Saal, Carmina Warth Pérez Arias, Anna‐Elisa Roser, Jan Christoph Koch, Mathias Bähr, Silvio O. Rizzoli, Paul Lingor
    Journal of Neurochemistry.2021; 157(4): 1052.     CrossRef
  • A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
    Na-Ra Han, Yu-Kang Kim, Sora Ahn, Tae-Yeon Hwang, Hyejung Lee, Hi-Joon Park
    Frontiers in Aging Neuroscience.2021;[Epub]     CrossRef
  • Association of Parkinson’s Disease With Microbes and Microbiological Therapy
    Zhao-Ji Chen, Cheng-Yu Liang, Li-Qing Yang, Si-Min Ren, Yan-Min Xia, Lei Cui, Xiao-Fang Li, Bu-Lang Gao
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease
    Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin
    Journal of Parkinson's Disease.2021; 11(3): 1129.     CrossRef
  • The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson’s Disease
    Melissa Vos, Christine Klein
    Cells.2021; 10(3): 579.     CrossRef
  • Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
    Verónica Sambra, Francisca Echeverria, Alfonso Valenzuela, Raphaël Chouinard-Watkins, Rodrigo Valenzuela
    Nutrients.2021; 13(3): 986.     CrossRef
  • What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
    Paola Tirassa, Tommaso Schirinzi, Marcello Raspa, Massimo Ralli, Antonio Greco, Antonella Polimeni, Roberta Possenti, Nicola Biagio Mercuri, Cinzia Severini
    Neuroscience & Biobehavioral Reviews.2021; 131: 899.     CrossRef
  • Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway
    Xiaoyue Zhao, Dewen Kong, Qimeng Zhou, Guangyi Wei, Junke Song, Yu Liang, Guanhua Du
    Biomedicine & Pharmacotherapy.2021; 140: 111556.     CrossRef
  • Apathy and actions- another consideration when theorizing about embodied nature of language in Parkinson's disease
    Logan Wolff, Jared F. Benge, Samia Ortiz-Hernandez, Samantha Beevers, Alexandra Armitage, Jungjun Park, Daniel L. Drane
    Journal of Communication Disorders.2021; 93: 106144.     CrossRef
  • Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson’s disease
    Ran Zheng, Song Qiao, Ying Chen, Chongyao Jin, Yi Fang, Zhihao Lin, Naijia Xue, Yiqun Yan, Luyan Gu, Ting Gao, Jun Tian, Yaping Yan, Xinzhen Yin, Jiali Pu, Baorong Zhang
    Neuroscience Letters.2021; 762: 136150.     CrossRef
  • Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study
    Sara Liguori, Antimo Moretti, Angela Palomba, Marco Paoletta, Francesca Gimigliano, Rosa De Micco, Mattia Siciliano, Alessandro Tessitore, Giovanni Iolascon
    NeuroRehabilitation.2021; 49(3): 481.     CrossRef
  • The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
    Qing Wang, Yuqi Luo, K Ray Chaudhuri, Richard Reynolds, Eng-King Tan, Sven Pettersson
    Brain.2021; 144(9): 2571.     CrossRef
  • Clinical features contributing to the sit-to-stand transfer in people with Parkinson’s disease: a systematic review
    Charmaine Pearl Da Cunha, Pratiksha Tilak Rao, Suruliraj Karthikbabu
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2021;[Epub]     CrossRef
  • Integration of Aluminium Interdigitated Electrodes with Zinc Oxide as Nanocomposite for Selectively Detect Alpha-Synuclein for Parkinson’s Disease Diagnosis
    Hussaini Adam, Subash C. B Gopinath, Uda Hashim
    Journal of Physics: Conference Series.2021; 2129(1): 012094.     CrossRef
  • Effects of depression and exercise on health-related quality of life in patients with Parkinson's disease
    George W Koutsouras, Kimberly Levine, Nathalie Duroseau, Christina Ciraco, Vivian Chan, Kathleen Pergament, Thomas Chan, Jayme D Mancini, Adena N Leder, Bhuma Krishnamachari
    Chronic Illness.2020; 16(3): 190.     CrossRef
  • Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons In Vitro and Enhances Dopamine Release In Vivo
    Arun Kumar Mahato, Jaakko Kopra, Juho‐Matti Renko, Tanel Visnapuu, Ilari Korhonen, Nita Pulkkinen, Maxim M. Bespalov, Andrii Domanskyi, Eric Ronken, T. Petteri Piepponen, Merja H. Voutilainen, Raimo K. Tuominen, Mati Karelson, Yulia A. Sidorova, Mart Saar
    Movement Disorders.2020; 35(2): 245.     CrossRef
  • Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
    Xiao-Jun Feng, Yu-Ting Huang, Ying-Zu Huang, Chi-Wei Kuo, Chih-Wei Peng, Alexander Rotenberg, Chi-Hung Juan, Yu-Cheng Pei, Yuan-Hao Chen, Kai-Yun Chen, Yung-Hsiao Chiang, Hui-Hua Liu, Jian-Xian Wu, Tsung-Hsun Hsieh
    Brain Stimulation.2020; 13(3): 655.     CrossRef
  • Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications
    Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn
    Geriatrics & Gerontology International.2020; 20(5): 443.     CrossRef
  • The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease
    Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho
    Journal of Parkinson's Disease.2020; 10(2): 605.     CrossRef
  • Assessments of plasma acyl-ghrelin levels in Parkinson’s disease patients treated with deep brain stimulation
    Wojciech Pietraszko, Agata Furgala, Agnieszka Gorecka-Mazur, Borys Kwinta, Jolanta Kaszuba-Zwoinska, Jaroslaw Polak, Urszula Fiszer, Krzysztof Gil, Anna Krygowska-Wajs
    Peptides.2020; 128: 170299.     CrossRef
  • Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
    Stefan Lang, Zahinoor Ismail, Mekale Kibreab, Iris Kathol, Justyna Sarna, Oury Monchi
    Human Brain Mapping.2020; 41(13): 3749.     CrossRef
  • Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
    Dorines Rosario, Jan Boren, Mathias Uhlen, Gordon Proctor, Dag Aarsland, Adil Mardinoglu, Saeed Shoaie
    Frontiers in Neuroscience.2020;[Epub]     CrossRef
  • Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila
    Iván Fernández-Cruz, Iván Sánchez-Díaz, Verónica Narváez-Padilla, Enrique Reynaud
    IBRO Reports.2020; 9: 65.     CrossRef
  • Boxing to Improve Sleep Quality and Daytime Sleepiness in Individuals With Parkinson Disease
    Macy Urrutia, Cynthia Ivy, Patricia S. Pohl, Linda Denney
    Topics in Geriatric Rehabilitation.2020; 36(3): 170.     CrossRef
  • Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
    Vanessa Castelli, Michele d’Angelo, Francesca Lombardi, Margherita Alfonsetti, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Paola Palumbo, Maria Grazia Cifone, Antonio Giordano, Giovambattista Desideri, Annamaria Cimini
    Aging.2020; 12(5): 4641.     CrossRef
  • Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease
    Jeong Hoon Park, Seung Hwan Lee, Yeshin Kim, Sang‐Won Park, Gi Hwan Byeon, Jae‐Won Jang
    Psychogeriatrics.2020; 20(6): 880.     CrossRef
  • Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions
    Soo Bin Park, Kyum-Yil Kwon, Jeong-Yoon Lee, Kayeong Im, Jun-Sang Sunwoo, Kyung Bok Lee, Hakjae Roh, Moo-Young Ahn, Suyeon Park, Soo-Jong Kim, Jungsu S. Oh, Jae Seung Kim
    Neurological Sciences.2019; 40(2): 311.     CrossRef
  • Cognitive Problems in Parkinson Disease: Perspectives and Priorities of Patients and Care Partners
    Katrina L. Raein, Samia Ortiz-Hernández, Jared F. Benge
    Cognitive and Behavioral Neurology.2019; 32(1): 16.     CrossRef
  • Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
    Sunil Srivastav, Sabita Neupane, Sunil Bhurtel, Nikita Katila, Sailesh Maharjan, Hyukjae Choi, Jin Tae Hong, Dong-Young Choi
    The Journal of Nutritional Biochemistry.2019; 69: 73.     CrossRef
  • Asymptomatic Hearing Impairment Frequently Occurs in Early-Onset Parkinson’s Disease
    Kuldeep Shetty, Syam Krishnan, Jissa Vinoda Thulaseedharan, Manju Mohan, Asha Kishore
    Journal of Movement Disorders.2019; 12(2): 84.     CrossRef
  • Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases
    Alon Seifan, Christine A. Ganzer, Krista Ryon, Michael Lin, Rahman Mahmudur, Henriquez Adolfo, Cindy Shih, Alan R. Jacobs, Molly Greenwald, Richard S. Isaacson
    Current Aging Science.2019; 11(4): 242.     CrossRef
  • Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson’s Disease
    Megan C. Bakeberg, Alexa Jefferson, Maddeson Riley, Michelle Byrnes, Soumya Ghosh, Frank L. Mastaglia, Malcom K. Horne, Sarah McGregor, Rick Stell, Jade Kenna, Sue Walters, Dana Hince, Ryan S. Anderton
    Parkinson's Disease.2019; 2019: 1.     CrossRef
  • α-Synuclein in Parkinson’s disease: causal or bystander?
    Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Classen, Christian Dresel, Wolfgang Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, Sabrina Strobel, Thilo van Eimeren, Hans-Ullrich Völker, Jürgen Winkler,
    Journal of Neural Transmission.2019; 126(7): 815.     CrossRef
  • Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease
    Motoki Okano, Kazue Takahata, Junya Sugimoto, Shizuko Muraoka
    Frontiers in Behavioral Neuroscience.2019;[Epub]     CrossRef
  • Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease
    Mi Sun Sung, Seong-Min Choi, Jonghwa Kim, Jun Young Ha, Byeong-Chae Kim, Hwan Heo, Sang Woo Park
    Scientific Reports.2019;[Epub]     CrossRef
  • Probiotics for Parkinson’s Disease
    Gazerani
    International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
  • The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
    Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, Wei Wu, Mengyu Lai, Xixi Zhang, Jie Li, Zhiling Guan, Huafen Zhao, Wen Li, Hongli Gao, Xiangmei Zhou, Lifeng Yang
    Frontiers in Neurology.2019;[Epub]     CrossRef
  • Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson’s Disease
    Wan-Ling Tsai, Hsin-Yung Chen, Ying-Zu Huang, Yuan-Hao Chen, Chi-Wei Kuo, Kai-Yun Chen, Tsung-Hsun Hsieh
    Behavioural Neurology.2019; 2019: 1.     CrossRef
  • The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson’s disease
    Keita Matsuura, Hiroyuki Kajikawa, Ken-ichi Tabei, Masayuki Satoh, Hirotaka Kida, Naoko Nakamura, Hidekazu Tomimoto
    Neuroscience Letters.2018; 662: 158.     CrossRef
  • Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms
    D. Santos-García, E. Suárez-Castro, J. Ernandez, I. Expósito-Ruiz, C. Tuñas-Gesto, M. Aneiros-Díaz, T. de Deus-Fonticoba, M. López-Fernández, D. Núñez-Arias
    Journal of Geriatric Psychiatry and Neurology.2018; 31(1): 19.     CrossRef
  • Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
    Paula Perez-Pardo, Laus M. Broersen, Tessa Kliest, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
    Frontiers in Aging Neuroscience.2018;[Epub]     CrossRef
  • Ghrelin and Neurodegenerative Disorders—a Review
    Limin Shi, Xixun Du, Hong Jiang, Junxia Xie
    Molecular Neurobiology.2017; 54(2): 1144.     CrossRef
  • The neurological effects of ghrelin in brain diseases: Beyond metabolic functions
    Qian Jiao, Xixun Du, Yong Li, Bing Gong, Limin Shi, Tingting Tang, Hong Jiang
    Neuroscience & Biobehavioral Reviews.2017; 73: 98.     CrossRef
  • First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
    Dale B. Schenk, Martin Koller, Daniel K. Ness, Sue G. Griffith, Michael Grundman, Wagner Zago, Jay Soto, George Atiee, Susanne Ostrowitzki, Gene G. Kinney
    Movement Disorders.2017; 32(2): 211.     CrossRef
  • Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
    J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee
    European Journal of Neurology.2017; 24(2): 349.     CrossRef
  • α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
    Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
    Neurological Sciences.2017; 38(1): 171.     CrossRef
  • Use of monoamine oxidase inhibitors in chronic neurodegeneration
    Peter Riederer, Thomas Müller
    Expert Opinion on Drug Metabolism & Toxicology.2017; 13(2): 233.     CrossRef
  • Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
    Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
    Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
  • Retinal biomarkers provide “insight” into cortical pharmacology and disease
    Christine T.O. Nguyen, Flora Hui, Jason Charng, Shajan Velaedan, Anna K. van Koeverden, Jeremiah K.H. Lim, Zheng He, Vickie H.Y. Wong, Algis J. Vingrys, Bang V. Bui, Magnus Ivarsson
    Pharmacology & Therapeutics.2017; 175: 151.     CrossRef
  • Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
    Paula Perez-Pardo, Esther M. de Jong, Laus M. Broersen, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
    Frontiers in Aging Neuroscience.2017;[Epub]     CrossRef
  • DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
    Moran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, Avner Thaler, Avi Orr Urterger, Susan Bressman, Karen Marder, Talma Hendler, Nir Giladi, Dafna Ben Bashat, Anat Mirelman, Elisa Greggio
    PLOS ONE.2017; 12(4): e0175424.     CrossRef
  • The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
    Paula Perez-Pardo, Tessa Kliest, Hemraj B. Dodiya, Laus M. Broersen, Johan Garssen, Ali Keshavarzian, Aletta D. Kraneveld
    European Journal of Pharmacology.2017; 817: 86.     CrossRef
  • Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms
    Mayela Rodríguez-Violante, Rosalía Zerón-Martínez, Amin Cervantes-Arriaga, Teresa Corona
    Archives of Medical Research.2017; 48(3): 221.     CrossRef
  • Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
    Paula Perez-Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld
    Current Behavioral Neuroscience Reports.2017; 4(4): 361.     CrossRef
  • The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
    Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis, Alice Cronin‐Golomb
    Movement Disorders.2016; 31(1): 23.     CrossRef
  • Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
    Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, Si-Hoon Lee, Jeong-Wook Park, Byung-chul Son, Kwang-Soo Lee
    Journal of the Neurological Sciences.2016; 362: 59.     CrossRef
  • Relearning of Writing Skills in Parkinson's Disease After Intensive Amplitude Training
    Evelien Nackaerts, Elke Heremans, Griet Vervoort, Bouwien C.M. Smits‐Engelsman, Stephan P. Swinnen, Wim Vandenberghe, Bruno Bergmans, Alice Nieuwboer
    Movement Disorders.2016; 31(8): 1209.     CrossRef
  • Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease
    Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Sung-Kyung Park, Si-Ryung Han, Kwang-Soo Lee
    Journal of Movement Disorders.2016; 9(2): 97.     CrossRef
  • The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
    Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
    Journal of Clinical Neurology.2016; 12(4): 393.     CrossRef
  • Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
    Esteban Luna, Kelvin C. Luk
    FEBS Letters.2015; 589(24PartA): 3749.     CrossRef
  • Differentiated Cells Derived from Fetal Neural Stem Cells Improve Motor Deficits in a Rat Model of Parkinson's Disease
    Wei Wang, Hao Song, Aifang Shen, Chao Chen, Yanming Liu, Yabing Dong, Fabin Han
    Translational Neuroscience and Clinics.2015; 1(2): 75.     CrossRef
Original Article
Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia
Yoon-Sang Oh, Joong-Seok Kim, Phil Hyu Lee
J Mov Disord. 2015;8(2):98-102.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15041
  • 20,335 View
  • 255 Download
  • 26 Web of Science
  • 28 Crossref
AbstractAbstract PDF
Objective A recent study showed that rivastigmine and memantin improved behavioral and psychiatric symptoms of dementia (BPSD) in Alzheimer’s dementia. Furthermore, according to recent guidelines presented by the Movement Disorder Society, rivastigmine is efficacious for the treatment of dementia in Parkinson’s disease (PD). We investigated the efficacy of rivastigmine for BPSD in patients with Parkinson’s disease dementia (PDD).
Methods Twenty-three patients in whom cognitive impairment occurred at least one year after a diagnosis of PD participated in this open-label trial. Cognitive, psychiatric, and motor symptoms were assessed before and after 24 weeks of treatment with rivastigmine using unstructured clinical assessments and rating scales including the Unified Parkinson’s Disease Rating Scale, Mini-Mental State Examination (MMSE), and the Neuropsychiatric Inventory.
Results Age (± standard deviation) was 74.7 ± 5.9 years, average duration of PD was 3.5 ± 3.7 years, Hoehn and Yahr scores were 2.2 ± 0.8, and baseline MMSE scores were 19.1 ± 4.2. Improvements in global mental symptoms and neuropsychiatric symptoms were significant; among them, hallucination, depression and appetite changes improved. Caregiver distress significantly decreased, including distress resulting from hallucinations, depression, apathy, and appetite changes.
Conclusions Although controlled trials are required, the findings suggest that rivastigmine is useful for control of several neuropsychiatric symptoms and beneficial for caregiver distress in patients with PDD.

Citations

Citations to this article as recorded by  
  • Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
    Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, Anastasia Bougea, Dionysia Kontaxopoulou, Stella Fragkiadaki, Christos Koros, Vasiliki Epameinondas Georgakopoulou, George Fotakopoulos, Yiannis Koutedakis, Christina Piperi, Sokratis
    Medicina.2023; 59(8): 1454.     CrossRef
  • Parkinsonism and dementia
    Christos Koros, Leonidas Stefanis, Nikolaos Scarmeas
    Journal of the Neurological Sciences.2022; 433: 120015.     CrossRef
  • Current concepts in treating mild cognitive impairment in Parkinson's disease
    Jay S. Schneider, Sandhya Kortagere
    Neuropharmacology.2022; 203: 108880.     CrossRef
  • Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
    Ségolène De Waele, Patrick Cras, David Crosiers
    Brain Sciences.2022; 12(7): 923.     CrossRef
  • Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
    Łucja Justyna Walczak-Nowicka, Mariola Herbet
    International Journal of Molecular Sciences.2021; 22(17): 9290.     CrossRef
  • Diagnosis and treatment of old-onset Parkinson's disease
    久大 立花
    Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2021; 58(3): 341.     CrossRef
  • Neuropsychiatrische Störungen bei idiopathischem Parkinson-Syndrom
    Mario Paulig
    Nervenheilkunde.2021; 40(10): 752.     CrossRef
  • Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
    Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michaud
    Medicina.2021; 57(10): 1107.     CrossRef
  • Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy
    Paolo Morana, Federico Mucci, Stefano Baroni, Alessandra Della Vecchia, Armando Piccinni, Benedetto Morana, Donatella Marazziti
    Clinical Case Reports.2020; 8(2): 254.     CrossRef
  • Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
    Kathy Dujardin, Véronique Sgambato
    Frontiers in Neuroscience.2020;[Epub]     CrossRef
  • Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson’s Disease, and Multiple Sclerosis: Diagnosis and Treatment
    Susan K. Conroy, Katherine B. Brownlowe, Thomas W. McAllister
    FOCUS.2020; 18(2): 150.     CrossRef
  • Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice
    Claudia Lazcano-Ocampo, Yi Min Wan, Daniel J van Wamelen, Lucia Batzu, Iro Boura, Nataliya Titova, Valentina Leta, Mubasher Qamar, Pablo Martinez-Martin, K Ray Chaudhuri
    Expert Review of Neurotherapeutics.2020; 20(5): 477.     CrossRef
  • Diagnosis, treatment and management of apathy in Parkinson’s disease: a scoping review
    Bria Mele, Shinia Van, Jayna Holroyd-Leduc, Zahinoor Ismail, Tamara Pringsheim, Zahra Goodarzi
    BMJ Open.2020; 10(9): e037632.     CrossRef
  • Pharmacological treatment of apathy in Lewy body disorders: A systematic review
    Jennifer Liu, Christine A. Cooper, Daniel Weintraub, Nabila Dahodwala
    Parkinsonism & Related Disorders.2019; 60: 14.     CrossRef
  • Current treatment of behavioral and cognitive symptoms of Parkinson's disease
    Irena Rektorova
    Parkinsonism & Related Disorders.2019; 59: 65.     CrossRef
  • Approach to the management of psychosis in Parkinson’s disease
    Abhishek Lenka, Vasanthi Gomathinayagam, Laxman Bahroo
    Annals of Movement Disorders.2019; 2(3): 83.     CrossRef
  • Risk factors for non-motor symptoms in Parkinson's disease
    Johan Marinus, Kangdi Zhu, Connie Marras, Dag Aarsland, Jacobus J van Hilten
    The Lancet Neurology.2018; 17(6): 559.     CrossRef
  • The efficacy of pharmacological approaches to therapy of the apathy syndrome in dementia disorders (the review)
    A. S. Avedisova, A. B. Guekht, K. V. Zakharova, R. G. Akzhigitov
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2018; 118(4): 126.     CrossRef
  • Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle
    Rita Moretti, Paola Caruso, Matteo Dal Ben
    Parkinson's Disease.2017; 2017: 1.     CrossRef
  • Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature
    Philip E. Mosley, Rebecca Moodie, Nadeeka Dissanayaka
    Journal of Geriatric Psychiatry and Neurology.2017; 30(5): 235.     CrossRef
  • Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson’s Disease: Implication for Treatment
    Stephane Thobois, Stephane Prange, Véronique Sgambato-Faure, Léon Tremblay, Emmanuel Broussolle
    Current Neurology and Neuroscience Reports.2017;[Epub]     CrossRef
  • Parkinson's disease psychosis: presentation, diagnosis and management
    Ruth B Schneider, Julia Iourinets, Irene H Richard
    Neurodegenerative Disease Management.2017; 7(6): 365.     CrossRef
  • Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson’s Disease
    Yunlong Zhang, Feng Tan, Pingyi Xu, Shaogang Qu
    Neural Plasticity.2016; 2016: 1.     CrossRef
  • Neuropsychiatric Issues in Parkinson’s Disease
    Jeffrey W. Cooney, Mark Stacy
    Current Neurology and Neuroscience Reports.2016;[Epub]     CrossRef
  • Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists
    Daniel Martinez-Ramirez, Michael S Okun, Michael S Jaffee
    Neurodegenerative Disease Management.2016; 6(4): 319.     CrossRef
  • Pimavanserin for the treatment of Parkinson’s disease psychosis
    Ines Chendo, Joaquim J Ferreira
    Expert Opinion on Pharmacotherapy.2016; 17(15): 2115.     CrossRef
  • Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments
    Fleur Harrison, Liesbeth Aerts, Henry Brodaty
    Current Psychiatry Reports.2016;[Epub]     CrossRef
  • Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration
    Santiago Perez-Lloret, María Cecilia Peralta, Francisco J. Barrantes
    Expert Opinion on Pharmacotherapy.2016; 17(18): 2405.     CrossRef
Letters to the editor
Two Cases of Secondary Hemifacial Spasm: Pathophysiology and Management
Frederick A. Zeiler, Anthony M. Kaufmann
J Mov Disord. 2015;8(2):103-105.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15004
  • 11,554 View
  • 82 Download
  • 3 Web of Science
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • A Case Report of Hemifacial Spasm Caused by Vestibular Schwannoma and Literature Review
    Xiaomin Cai, Yinda Tang, Hua Zhao, Zheng Chen, Haopeng Wang, Wanchun Zhu, Shiting Li
    Brain Sciences.2022; 12(10): 1347.     CrossRef
Parkinsonism and Dementia Associated with Giant Virchow-Robin Spaces
Myung Sik Lee, Cheol Hyung Lyoo, Tae Sub Chung
J Mov Disord. 2015;8(2):106-107.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15013
  • 12,495 View
  • 78 Download
  • 6 Web of Science
  • 9 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Espacios de Virchow-Robin mesencefálicos y parkinsonismo: caso clínico y revisión de la literatura
    M.O. Iridoy, P. Clavero, T. Cabada, M.E. Erro
    Neurología.2021; 36(2): 171.     CrossRef
  • Midbrain Virchow-Robin spaces and Parkinsonism: A case report and literature review
    M.O. Iridoy, P. Clavero, T. Cabada, M.E. Erro
    Neurología (English Edition).2021; 36(2): 171.     CrossRef
  • Cognitive impairment due to widespread enlarged perivascular spaces
    Yoshitaka Yamaguchi, Manabu Wada, Luna Kimihira, Hikaru Nagasawa
    Radiology Case Reports.2021; 16(9): 2640.     CrossRef
  • Aberrant Neurogliovascular Unit Dynamics in Cerebral Small Vessel Disease: A Rheological Clue to Vascular Parkinsonism
    Che Mohd Nasril Che Mohd Nassir, Thenmoly Damodaran, Siti R. Yusof, Anwar Norazit, Geetha Chilla, Isaac Huen, Bhanu Prakash K. N., Norlinah Mohamed Ibrahim, Muzaimi Mustapha
    Pharmaceutics.2021; 13(8): 1207.     CrossRef
  • Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous System
    Fernanda Troili, Virginia Cipollini, Marco Moci, Emanuele Morena, Miklos Palotai, Virginia Rinaldi, Carmela Romano, Giovanni Ristori, Franco Giubilei, Marco Salvetti, Francesco Orzi, Charles R. G. Guttmann, Michele Cavallari
    Frontiers in Neuroanatomy.2020;[Epub]     CrossRef
  • Tumefactive Virchow-Robin spaces
    Robert M. Kwee, Thomas C. Kwee
    European Journal of Radiology.2019; 111: 21.     CrossRef
  • Dilated Virchow-Robin space and Parkinson's disease: A case report of combined MRI and diffusion tensor imaging
    Renata Conforti, Angela Sardaro, Alberto Negro, Giuseppina Caiazzo, Antonella Paccone, Rosita De Micco, Sossio Cirillo, Alessandro Tessitore
    Radiology Case Reports.2018; 13(4): 871.     CrossRef
  • Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis
    Alice Favaretto, Andrea Lazzarotto, Alice Riccardi, Stefano Pravato, Monica Margoni, Francesco Causin, Maria Giulia Anglani, Dario Seppi, Davide Poggiali, Paolo Gallo, Dzung Pham
    PLOS ONE.2017; 12(10): e0185626.     CrossRef
  • Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis
    Do-Young Kwon
    Journal of Movement Disorders.2016; 9(2): 63.     CrossRef

JMD : Journal of Movement Disorders